NUCLEAR-DELIVERED CONJUGATES Trademark

Trademark Overview

On Tuesday, December 17, 2019, a trademark application was filed for NUCLEAR-DELIVERED CONJUGATES with the United States Patent and Trademark Office. The USPTO has given the NUCLEAR-DELIVERED CONJUGATES trademark a serial number of 88730044. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 1, 2020. This trademark is owned by Angiex, Inc.. The NUCLEAR-DELIVERED CONJUGATES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for the treatment of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease

Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; medical and scientific research for the detection of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease; providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
nuclear-delivered conjugates

General Information

Serial Number88730044
Word MarkNUCLEAR-DELIVERED CONJUGATES
Filing DateTuesday, December 17, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 1, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease
Goods and ServicesScientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; medical and scientific research for the detection of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease; providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAngiex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Thursday, October 1, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020ASSIGNED TO EXAMINER
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 20, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

conjugates delivered nuclear tissue diseases cardiovascular disease conditions repair inflammatory cancer immunological research